Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes of Stockholders??? Equity (Deficit) (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Changes of Stockholders’ Equity (Deficit) (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2022   1,312,521    
Beginning Balance at Dec. 31, 2022 $ 27,819 $ 131 $ 68,132,790 $ (68,105,102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 3,077,027   3,077,027  
Vesting of RSUs (in shares)   4,603    
Vesting of RSUs 0 $ 1 (1)  
Exercise of warrants (in shares)   8,293    
Exercise of warrants 338,055   338,055  
Conversion of convertible secured debentures 0      
Exercise of stock options (in shares)   4,979    
Exercise of stock options 342,579 $ 0 342,579  
Net income (loss) 6,534,775     6,534,775
Ending Balance (in shares) at Jun. 30, 2023   1,330,396    
Ending Balance at Jun. 30, 2023 10,320,255 $ 132 71,890,450 (61,570,327)
Beginning Balance (in shares) at Mar. 31, 2023   1,313,369    
Beginning Balance at Mar. 31, 2023 (12,836,794) $ 131 69,406,842 (82,243,767)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 1,862,164   1,862,164  
Vesting of RSUs (in shares)   4,603    
Vesting of RSUs 0 $ 1 (1)  
Exercise of warrants (in shares)   8,293    
Exercise of warrants 338,055   338,055  
Exercise of stock options (in shares)   4,131    
Exercise of stock options 283,390   283,390  
Net income (loss) 20,673,440     20,673,440
Ending Balance (in shares) at Jun. 30, 2023   1,330,396    
Ending Balance at Jun. 30, 2023 10,320,255 $ 132 71,890,450 (61,570,327)
Beginning Balance (in shares) at Dec. 31, 2023   1,389,884    
Beginning Balance at Dec. 31, 2023 (41,786,850) $ 139 77,004,714 (118,791,703)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 1,339,965   1,339,965  
Vesting of RSUs (in shares)   90,587    
Vesting of RSUs $ 0 $ 9 (9)  
Exercise of warrants (in shares) 22,161,186 615,589    
Exercise of warrants $ 4,451,163 $ 61 4,451,102  
Conversion of convertible secured debentures (in shares)   628,942    
Conversion of convertible secured debentures 2,237,398 $ 63 2,237,335  
At the Market (ATM) share offering (in shares)   1,406,424    
At the Market (ATM) share offering 9,357,954 $ 141 9,357,813  
Net income (loss) (4,959,708)     (4,959,708)
Ending Balance (in shares) at Jun. 30, 2024   4,131,426    
Ending Balance at Jun. 30, 2024 (29,360,078) $ 413 94,390,920 (123,751,411)
Beginning Balance (in shares) at Mar. 31, 2024   1,592,140    
Beginning Balance at Mar. 31, 2024 (39,502,929) $ 159 78,875,003 (118,378,091)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock-based compensation 809,310   809,310  
Vesting of RSUs (in shares)   46,665    
Vesting of RSUs 0 $ 5 (5)  
Exercise of warrants (in shares)   457,255    
Exercise of warrants 3,111,509 $ 45 3,111,464  
Conversion of convertible secured debentures (in shares)   628,942    
Conversion of convertible secured debentures 2,237,398 $ 63 2,237,335  
At the Market (ATM) share offering (in shares)   1,406,424    
At the Market (ATM) share offering 9,357,954 $ 141 9,357,813  
Net income (loss) (5,373,320)     (5,373,320)
Ending Balance (in shares) at Jun. 30, 2024   4,131,426    
Ending Balance at Jun. 30, 2024 $ (29,360,078) $ 413 $ 94,390,920 $ (123,751,411)